Patent · US Active

Modified release tranexamic acid formulation

US8597683B2 · kind B2 · utility

0Cited by
4References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2010
Grant dateDec 3, 2013
Priority date—
Expiry dateOct 14, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P7/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A modified release dosage form for the oral administration of tranexamic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.